farnesol and Metabolic Diseases

farnesol has been researched along with Metabolic Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Funakoshi, K; Goto, T; Hirai, S; Horio, F; Inoue, H; Kawada, T; Kim, YI; Lee, JY; Makishima, M; Matsunaga, M; Nakata, R; Senju, H; Takahashi, N; Teraminami, A; Uemura, T	1

Other Studies

1 other study(ies) available for farnesol and Metabolic Diseases

Article	Year
Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways. American journal of physiology. Endocrinology and metabolism, 2011, Volume: 301, Issue:5 Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diet, High-Fat; Farnesol; Hepatocytes; Lipid Metabolism; Male; Metabolic Diseases; Mice; Mice, Knockout; Obesity; PPAR alpha; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Terpenes; Triglycerides	2011

Article

Year

Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.

American journal of physiology. Endocrinology and metabolism, 2011, Volume: 301, Issue:5

Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diet, High-Fat; Farnesol; Hepatocytes; Lipid Metabolism; Male; Metabolic Diseases; Mice; Mice, Knockout; Obesity; PPAR alpha; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Terpenes; Triglycerides

2011